ÂÜÀòÂÒÂ×

Dr. Stephen Riady was appointed Executive Chairman of OUE Limited on 9 March 2010., and as the Group Chief Executive Officer (in an expansion of his role as Executive Chairman) on 1 January 2020. He has been serving as Executive Director since 30 November 2006. He is a deemed substantial shareholder of OUE Limited. He was last re- elected as a Director at the Annual General Meeting held on 30 April 2019.

Dr. Riady is also an executive director of Lippo Limited and has been its chairman since 1991. He was appointed a director of Lippo China Resources Limited and Hongkong Chinese Limited in 1992 and in March 2011, he was appointed as chairman of both companies. Dr. Riady is the executive president of Lippo Limited, Lippo China Resources Limited and Hongkong Chinese Limited, which are all listed on the Main Board of The Stock Exchange of Hong Kong Limited. Dr. Riady is also a member of the remuneration committee and nomination committee of Lippo Limited, Lippo China Resources Limited and Hongkong Chinese Limited. He was also appointed a non-executive non-independent director of Healthway Medical Corporation Limited in August 2017, which is listed on the Catalist Board of the Singapore Exchange Securities Trading Limited.